CD4 and systemic lupus erythematosus: These results suggest that Naringenin have effects in the lupus manifestations through changes in the proportion of both CD4+CD44hiCD62L+ Tcm and CD4+CD44hiCD62L- Tem subsets associated with the pathogenesis of SLE.